VioQuest Pharmaceuticals Inc
VioQuest Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of clinical stage drug therapies for the treatment of oncology and infectious diseases. Its lead product includes Xyfid, which is under development for the treatment and prevention of hand-foot syndrome. The company's products also consist of VQD-002, a nucleoside analog tha… Read more
VioQuest Pharmaceuticals Inc (VOQP) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2008: 0.273x
Based on the latest financial reports, VioQuest Pharmaceuticals Inc (VOQP) has a cash flow conversion efficiency ratio of 0.273x as of June 2008.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.55 Million) by net assets ($-5.67 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
VioQuest Pharmaceuticals Inc - Cash Flow Conversion Efficiency Trend (1995–2007)
This chart illustrates how VioQuest Pharmaceuticals Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
VioQuest Pharmaceuticals Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of VioQuest Pharmaceuticals Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
TANTALIZERS PLC
XNSA:TANTALIZER
|
N/A |
|
TRIPPLE GEE AND COMPANY PLC
XNSA:TRIPPLEG
|
N/A |
|
US Solar Fund PLC
LSE:USFP
|
-0.004x |
|
American Graphite Technologies Inc
PINK:AGIN
|
-0.024x |
|
Regnum Corp
PINK:RGMP
|
0.237x |
|
MUTUAL BENEFITS ASSURANCE PLC
XNSA:MBENEFIT
|
N/A |
|
REAL ESTATE INVESTMENTS ZAMBIA PLC
LUSE:REIZUSD
|
N/A |
|
Manila Bulletin Publishing Corp
PSE:MB
|
0.005x |
Annual Cash Flow Conversion Efficiency for VioQuest Pharmaceuticals Inc (1995–2007)
The table below shows the annual cash flow conversion efficiency of VioQuest Pharmaceuticals Inc from 1995 to 2007.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2007-12-31 | $-4.48 Million | $-7.08 Million | 1.579x | +169.47% |
| 2006-12-31 | $2.84 Million | $-6.46 Million | -2.273x | -285.11% |
| 2005-12-31 | $6.34 Million | $-3.74 Million | -0.590x | +40.91% |
| 2004-12-31 | $3.79 Million | $-3.79 Million | -0.999x | +49.63% |
| 2003-12-31 | $825.33K | $-1.64 Million | -1.983x | -5289.61% |
| 2002-12-31 | $3.15 Million | $-115.96K | -0.037x | -111.02% |
| 2001-12-31 | $-46.86K | $-15.64K | 0.334x | +172.98% |
| 2000-12-31 | $151.23K | $-69.17K | -0.457x | -245.76% |
| 1999-12-31 | $188.11K | $59.03K | 0.314x | +257.58% |
| 1998-12-31 | $163.37K | $-32.53K | -0.199x | -162.03% |
| 1997-12-31 | $162.48K | $-12.35K | -0.076x | -1053.68% |
| 1996-12-31 | $232.41K | $1.85K | 0.008x | +121.33% |
| 1995-12-31 | $208.17K | $-7.78K | -0.037x | -- |